HealthDay News — Most speakers attending U.S. Food and Drug Administration (FDA) Human Drug Advisory Committee meetings about new drugs or indications support approval, according to a research letter ...

Serum urate (SU) levels rise sharply during the menopausal transition and remain elevated thereafter, suggesting that the risk for hyperuricemia and subsequent gout among women may begin years before ...

A large recall of shredded cheese sold under several popular grocery store brands is now underway after the manufacturer reported the product may contain small metal fragments.

Myopic progression and the development of pathological myopia are not only a concern in children, but in young highly myopic adults. According to new research in the British Journal of Ophthalmology, ...

The FDA is expected to decide on treatments for breast cancer, EBV+ post-transplant lymphoproliferative disease, focal segmental glomerulosclerosis, presbyopia, and severe allergic reactions.

Millions of people rely on continuous glucose monitors to help manage diabetes. But a new alert from the US Food and Drug Administration (FDA) warns that some sensors from Abbott may give incorrect ...

The US Food and Drug Administration (FDA) is facing even more leadership changes as drug regulator Dr. Richard Pazdur prepares to retire at the end of the month, the agency confirmed this week.

For the first time in more than three decades, the United States did not take part in World AIDS Day on December 1, a major change from past years when the day was used to raise awareness about ...

For patients with type 2 diabetes, there is an association between glucagon-like peptide-1 receptor agonist (GLP-1 RA) use and chronic cough.

Pregnant adolescents with SLE were more likely than healthy controls to have adverse pregnancy outcomes and more likely than ...

HealthDay News — Between 2000 and 2024, global measles deaths fell by 88%, saving an estimated 58 million lives, according to a new World Health Organization (WHO) report. But now the virus is ...

The oral small-molecule glucagon-like peptide 1 (GLP-1) receptor agonist orforglipron demonstrates superior weight loss as an adjunct to lifestyle modification versus placebo for adults with obesity ...